Cleveland Clinic Abu Dhabi Introduces Innovative Brain Aneurysm Device

Cleveland Clinic Abu Dhabi has set a new benchmark in treating brain aneurysms across the Middle East and North Africa (MENA) region. The hospital has adopted the first Artisse Intrasaccular Flow Modulator in the region, a revolutionary device designed to treat complex cerebral aneurysms more safely and effectively. Recognized by the Department of Health – Abu Dhabi as a Centre of Excellence (CoE), this achievement highlights the hospital’s leadership in stroke treatment and its dedication to adopting cutting-edge medical technology.

Understanding Brain Aneurysms

A brain aneurysm is a serious medical condition where a weakened area in a blood vessel wall in the brain bulges outward, forming a balloon-like shape. If left untreated, these aneurysms can rupture and cause a subarachnoid hemorrhage, a type of stroke caused by bleeding in the brain. Brain aneurysms are dangerous because they can lead to long-term neurological damage or even death if immediate treatment is not provided.

Stay informed with the latest news. Follow DXB News Network on WhatsApp Channel 

Traditionally, aneurysms have been treated through invasive open surgery, which requires physically opening the skull to access and repair the blood vessel. While effective, open surgery carries significant risks, including infection, longer recovery times, and potential complications. However, medical advancements over the last decade have introduced minimally invasive procedures that can treat aneurysms with far less risk, less pain, and faster recovery times.

How the Artisse Intrasaccular Flow Modulator Works

The Artisse device offers a minimally invasive solution for treating brain aneurysms, particularly those with wide necks that are difficult to manage using traditional methods. The procedure begins with a catheter inserted through the patient’s blood vessels, usually via the groin or arm, to reach the aneurysm in the brain.

Using advanced 3D imaging and angiograms, physicians can precisely visualize the aneurysm and assess its shape and size. Once in position, the Artisse device, a unique mesh structure, is deployed into the aneurysm. The device fills the aneurysm, stopping blood from entering and significantly lowering the risk of rupture. Unlike traditional treatments that often use multiple coils, the Artisse device is permanent, offering long-term protection without the need for further invasive surgery.

The procedure itself can take anywhere from 2 to 8 hours, depending on the aneurysm’s size and complexity. After the procedure, patients undergo regular follow-up imaging at 3 and 6 months to ensure the device is functioning correctly. In the first case at Cleveland Clinic Abu Dhabi, 3-month follow-up imaging confirmed successful treatment, showing that the aneurysm had been effectively sealed off.

A Leap Forward in Neurological Care

The introduction of the Artisse device is a major advancement in neurological care. Unlike traditional aneurysm treatments, which rely on multiple coils or filaments to block blood flow, the Artisse device uses a single, intricately designed mesh to close off the aneurysm. This approach is not only safer but also more efficient, reducing the chances of complications and improving long-term outcomes for patients.

Dr. Fayeza Al Yafie, Executive Director of the Healthcare Quality Sector at the Department of Health – Abu Dhabi, praised the hospital’s achievement: “Centres of Excellence in Abu Dhabi continue to affirm their commitment to enhancing the healthcare system by providing specialised care and utilising the emirate’s advanced infrastructure. Abu Dhabi’s dynamic regulatory environment encourages research and innovation, attracting talent and advanced technologies that benefit the health and safety of the community. We congratulate Cleveland Clinic Abu Dhabi on this milestone.”

Expert Opinions on the New Treatment

Dr. Khalil Zahra, Staff Physician, Neurosurgery, Neurological Institute at Cleveland Clinic Abu Dhabi, said: “The introduction of this technology enhances our ability to treat complex aneurysms and shows our commitment to bringing the latest medical advancements to our patients. Combined with our multidisciplinary approach, this device ensures world-class treatment for even the most challenging neurological conditions. The success of our first procedure marks a new era in brain aneurysm treatment, offering safer, less invasive options.”

Dr. Zahra emphasized that the adoption of the Artisse device is not just a one-time advancement. It is expected to pave the way for future innovation in neurological care. By gathering long-term data on patient outcomes, Cleveland Clinic Abu Dhabi aims to contribute valuable insights to the global neurosurgical community and further solidify its position as a leader in the MENA region.

Multidisciplinary Approach to Patient Care

Cleveland Clinic Abu Dhabi’s Neurological Institute follows a collaborative model, bringing together experts in neurosurgery, interventional neuroradiology, and neurology. This multidisciplinary approach ensures each patient receives a personalized treatment plan tailored to their specific condition. By combining expertise from various specialties with advanced technologies like the Artisse device, the hospital provides the best possible care for patients with complex brain conditions.

Centre of Excellence for Stroke

As a designated Centre of Excellence for stroke, Cleveland Clinic Abu Dhabi was chosen as the launch site for the Artisse device in the MENA region. The hospital’s focus on innovation, research, and high-quality patient care has made it a pioneer in neurological treatment. With this new device, Cleveland Clinic Abu Dhabi continues to enhance treatment options for patients, offering safer procedures, faster recovery, and improved outcomes.

Looking Ahead

The successful adoption of the Artisse Intrasaccular Flow Modulator marks a turning point in brain aneurysm treatment in the region. Dr. Zahra explained that this technology is a springboard for further research and development, helping physicians discover even more advanced ways to treat complex cerebrovascular conditions.

By combining technology, expertise, and patient-focused care, Cleveland Clinic Abu Dhabi demonstrates its dedication to improving neurological health and patient quality of life. The hospital remains at the forefront of innovation, constantly exploring new solutions to treat challenging brain conditions while ensuring patients receive safe and effective care.

Cleveland Clinic Abu Dhabi’s introduction of the Artisse device is a milestone in the MENA region, offering minimally invasive treatment for brain aneurysms and advancing global neurological care. With its multidisciplinary approach, cutting-edge technology, and commitment to patient safety, the hospital continues to set new standards in healthcare. The adoption of this innovative device is not only a breakthrough in treatment but also a symbol of the hospital’s leadership in research, innovation, and world-class patient care.

#Best News Network In Dubai #News In Abu Dhabi #Abu Dhabi latest updates #UAE NEWS #Top News Channel Dubai #breaking news